Samsung could battle Apple over non-invasive glucose monitors

A stock photo of the Galaxy Watch. [Image courtesy of Samsung]Bloomberg reports that Samsung has eyes on developing non-invasive glucose monitoring technology, potentially pitting it against Apple.

The report says the electronics company wants to develop continuous blood pressure checking along with glucose monitoring. It comes as part of an effort to incorporate health features in Samsung devices, like its Galaxy Ring, Bloomberg says. Hon Pak, a Samsung executive in charge of this push, told the outlet in an interview that the company is putting “significant investment” toward these new functions.

According to Bloomberg, Samsung is considering several possible avenues for this technology, including miniaturization. Pak expects to see non-invasive glucose monitoring hit the market in some form within five years, the outlet said.

While the report has no projected timeline for the Samsung project itself, if and when it moves forward, it will likel…

Read more
  • 0

FDA clears Samsung Galaxy smart watch for AFib detection

[Image courtesy of Samsung]Samsung Electronics announced that the irregular heart rhythm notification feature of its health monitor app received FDA clearance.

Combined with the app’s existing on-demand ECG function, the feature proactively monitors heart rhythms suggestive of AFib. It all works straight from the user’s wrist through the Samsung Galaxy Watch.

“We’re excited to announce that irregular heart rhythm notification, designed to help millions of people around the world who may not be aware of a potential heart risk, has been cleared by the FDA,” said Hon Pak, VP and head of the digital health team, MX business at Samsung Electronics. “This is yet another example of how Samsung prioritizes proactive safety solutions and enables users to receive a more holistic understanding of their cardiovascular and overall health.”

Galaxy Watch utilizes the Samsung BioActive sensor. It includes on-demand ECG recording and heart rhythm alert functions…

Read more
  • 0

FDA clears mobile CT scanner from Samsung’s NeuroLogica

The BodyTom 64. [Image from NeuroLogica]NeuroLogica — a Samsung Electronics subsidiary — announced today that it received FDA 510(k) clearance for its BodyTom 64 scanner.

Danvers, Massachusetts-based NeuroLogica designed its BodyTom 64 for point-of-care mobile computed tomography (CT).

BodyTom 64 offers revisions to the company’s software and data acquisition system (DAS) based on customer feedback. NeuroLogica incorporated Linux as the operating system and provided the ability to generate up to 64 cross-sectional CT images. This compares to 32 images produced by the previous version, the BodyTom Elite.

The scanner offers multi-departmental imaging that stretches across various needs. It can turn an operating room into an intraoperative neuro-imaging suite when combined with a radiolucent skull fixation device. This enhances neuro-navigation and surgical outcomes, according to a news release.

Additionally, BodyTom 64 combines internal lead shie…

Read more
  • 0